AntonioJimenoMD

Clinical Trials

• Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors Start of enrollment: 2009 Jan 01

  Completed

  Phase 1

• Safety, Pharmacokinetics and Clinical Activity of Oral Rigosertib in Solid Tumors Start of enrollment: 2010 Jul 01

  Completed

  Phase 1

• Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer Start of enrollment: 2011 Apr 01

  Completed

  Phase 1

• Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer Start of enrollment: 2011 May 01

  Completed

  Phase 3

• Study of PM01183 in Non-Colorectal Cancer Patients as a Days 1 and 8 Intravenous Short Infusion Every 3 Weeks Start of enrollment: 2011 Nov 01

  Completed

  Phase 1

• A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2012 Nov 12

  Terminated

  Phase 1, Phase 2

• Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14

  Completed

  Phase 2

• A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies Start of enrollment: 2013 Oct 01

  Completed

  Phase 1

• Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer Start of enrollment: 2014 Jan 01

  Completed

  Phase 1

• Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumors Start of enrollment: 2014 Jun 01

  Terminated

  Phase 1

• A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies Start of enrollment: 2014 Sep 05

  Completed

  Phase 1

• Join now to see all